Plasticity of DNA methylation in mouse T cell activation and differentiation
© Li et al; licensee BioMed Central Ltd. 2012
Received: 20 December 2011
Accepted: 29 May 2012
Published: 29 May 2012
Circulating CD4+ T helper cells are activated through interactions with antigen presenting cells and undergo differentiation into specific T helper cell subsets depending on the type of antigen encountered. In addition, the relative composition of the circulating CD4+ T cell population changes as animals mature with an increased percentage of the population being memory/effector type cells.
Here, we report on the highly plastic nature of DNA methylation at the genome-wide level as T cells undergo activation, differentiation and aging. Of particular note were the findings that DNA demethylation occurred rapidly following T cell activation and that all differentiated T cell populations displayed lower levels of global methylation than the non-differentiated population. In addition, T cells from older mice had a reduced level of DNA methylation, most likely explained by the increase in the memory/effector cell fraction. Although significant genome-wide changes were observed, changes in DNA methylation at individual genes were restricted to specific cell types. Changes in the expression of enzymes involved in DNA methylation and demethylation reflect in most cases the changes observed in the genome-wide DNA methylation status.
We have demonstrated that DNA methylation is dynamic and flexible in CD4+ T cells and changes rapidly both in a genome-wide and in a targeted manner during T cell activation, differentiation. These changes are accompanied by parallel changes in the enzymatic complexes that have been implicated in DNA methylation and demethylation implying that the balance between these opposing activities may play a role in the maintaining the methylation profile of a given cell type but also allow flexibility in a cell population that needs to respond rapidly to environmental signals.
KeywordsDNA demethylation T cell activation T cell differentiation Il2, Csf2
DNA methylation is one of the best characterized epigenetic modifications and changes in DNA methylation are associated with many biological processes. In higher organisms, a cell's phenotype, arising from alternative gene expression profiles, can be controlled at least in part by DNA methylation . To date, the most accepted hypothesis is that gene silencing is correlated with DNA methylation at the promoter regions of the genes, while hypomethylation at such regions is linked to gene activation. Genomic DNA methylation is generally stable in somatic cells but is known to undergo extensive reprogramming at various stages of mammalian development [2–5]. There are many studies demonstrating distinct methylation levels and profiles in different cell types [6–10]. For example, a study focused on identifying the differentially methylated regions (DMRs) between conventional CD4+ T cell (Tconv) and regulatory T cell (Treg) identified more than 100 DMRs that are present mainly at cell type-specific genes, such as FOXP3 and IL2RA . Recent studies have provided strong evidence that DNA methylation is much more dynamic and flexible than previously believed and have identified mechanisms of active DNA demethylation in addition to the well-described DNA methylating mechanisms [11–14]. One recent study employing bisulphite conversion-based MethylC-seq, has identified promoter-distal regions as the major site of dynamic changes in DNA methylation levels during ES cell differentiation . Another study employed a customized genome-wide methylation profiling method dubbed CHARM (comprehensive high-throughput arrays for relative methylation), and discovered waves of change in DNA methylation at 4.6 million potentially methylated sites during normal blood cell differentiation . These and other studies provide evidence that DNA methylation of the mammalian genome is not only cell-type specific but also highly flexible and dynamic.
Circulating mature CD4+ T cells are a highly flexible, mixed and dynamic population. The CD4+ T cell population is a mixture of naive (CD44-CD62L+), memory/effector (CD44+CD62L+/-) and regulatory cells (CD4+CD25+). The relative proportions of these circulating cell types change naturally with age and upon encountering antigens. In responding to activation through interaction with antigen presenting cells, CD4+ T cell undergo differentiation into numerous effector T helper cell types, such as Th1, Th2 and Th17, depending on the type of antigen encountered. As determined by the cell surface phenotypes and their functional characteristics, an increased proportion of T cells in elderly individuals is found to be highly differentiated as a consequence of repeated exposure to antigens and decreased production of naive T cells due to reduced thymopoiesis [17, 18]. These events lead to a greater proportion of the CD4+ T cells displaying an effector/memory phenotype. There have been numerous studies examining the role of DNA methylation in T cell activation and differentiation with a specific focus on individual genes. There is evidence that the level of DNA methylation changes at specific genes following T cell activation and differentiation. For example, reduced DNA methylation and stable DNase I hypersensitivity sites are observed at the Ifng and Il4 loci during Th1 and Th2 cell differentiation, respectively [19, 20] and DNA methylation at the FOXP3 locus is greatly diminished in Treg cells compared to undifferentiated naive T cells [21–25]. A study investigating the role of CD44 in EAE (experimental autoimmune encephalitomyelitis) revealed that CD44 promotes Th1/Th17 cell differentiation with hypomethylation at the Ifng and Il17a promoters, whereas deficiency of CD44 inhibits Th1/Th17 cell differentiation and simultaneously enhances Th2/Treg cell differentiation with hypermethylation of Ifng and Il17a and hypomethylation of Il4 . Thus, there is ample evidence supporting the idea that DNA demethylation or hypomethylation occurs at individual genes during the process of T cell differentiation.
It has also been well demonstrated that there are major changes in gene expression within a short time of the commencement of T cell activation and the role of associated changes in chromatin structure and histone modifications have been described . A more surprising result was reported several years ago in relation to rapid changes in DNA methylation following T cell activation . The promoter-enhancer region of the interleukin 2 gene was shown to undergo DNA demethylation within 20 minutes of stimulation in a transgenic T cell model . This demethylation was shown to be DNA replication-independent and the authors proposed a possible active enzymatic mechanism although there were no clear candidate enzymes at that time . Using reporter plasmids, DNA demethylation was confirmed to be necessary and sufficient to enhance transcription of Il2 . Another study has shown that DNA demethylation at a specific CpG site at the promoter-enhancer of IL2 promotes the recruitment of OCT 1 to its binding site and is regarded as a key epigenetic event in IL2 expression following CD4+ T cell activation .
DNA methylation is also known to be an age-dependent process occurring naturally in all cells/tissues in mammals. Hypermethylation is found in aging liver and sperm cells in rats and in humans [30–32]. In contrast, age-dependent hypomethylation in interspersed repetitive sequences is also observed . T cells produce less IL2 with age, and thus their function in elderly individuals is impaired [34, 35]. On the other hand, decreased expression of the methyltransferases, DNMT1 and DNMT3a, is associated with increased expression of certain other genes in T cells during aging . Although age-related DNA methylation in T cells is less well-studied, several studies have focused on the changes in DNA methylation in memory T cells. Production of cytokines, such as IL2, is increased in memory CD8+ T cells compared with naive cells and is correlated with DNA demethylation occurring at the promoters of these cytokine genes [37, 38]. These studies have all provided evidence that DNA methylation status, specifically at the promoters of inducible genes, is altered during T cell differentiation, activation and development.
DNA methylation and demethylation are two opposing epigenetic processes in genome regulation and the balance between them may help determine the level of genomic methylation in a given cell type. The DNA methyltransferases are part of the DNA methylation machinery required for maintaining genome stability through methylation of appropriate genomic regions . These DNA methyltransferases, namely DNMT1, DNMT3a and DNMT3b, not only act as enzymes for maintaining genomic DNA methylation, but are also regarded as mediators of gene transcriptional silencing .
In addition to the DNA methyltransferases, the discovery of novel enzymes involved in active DNA demethylation has led to the idea that there may be a balance in the methylating and demethylating enzymatic activities that determines the level of genomic DNA methylation in any given cell. Although DNA demethylation was initially thought to occur only during DNA replication , active DNA demethylation has now been shown to occur independently of DNA replication and is involved in many developmental and physiological processes in animals and plants [11, 12, 14]. In plants, active DNA demethylation is important in controlling the activity of the RNA-directed DNA methylation pathway, and thus preventing the spread of methylation from repetitive sequences to their neighbouring genes . In animals, several enzymatic complexes have recently been linked with active DNA demethylation [11, 14]. Deaminases, including the AICDA and APOBEC family, are enzymes that catalyse the removal of -NH2 from DNA, and are responsible for hypermutation of their target substrates [42, 43]. Glycosylases, such as Methyl-CpG-binding protein 4 (MBD4) and thymine DNA glycosylase (TDG), have also been reported to be involved in base excision repair and repair of T:G mismatches. MBD4 is one of the known thymine glycosylases and binds preferentially to 5mCpG · TpG mismatches, followed by efficient removal of thymine or uracil from a mismatched CpG site in vitro . These enzymatic activities are now thought to act in a novel pathway of DNA demethylation . A member of the Gadd45 family, Gadd45a, promotes the coupling process of an enzyme complex containing a cytosine deaminase, AICDA and a glycosylase, MBD4 . An interesting study using Gadd45b knockout mice has recently revealed that GADD45b is required for activation-induced DNA demethylation of specific promoters and expression of corresponding genes critical for adult neurogenesis, including brain-derived neurotrophic factor and fibroblast growth factor .
DNA demethylation also occurs during embryonic stem (ES) cell differentiation via the Ten-eleven-translocation enzymes (TET1, TET2 and TET3) that catalyse the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) [46, 47]. In addition to 5hmC, the TET enzymes are also capable of generating other minor products, such as 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) . 5caC can be specifically recognised and repaired by thymine DNA glycosylase (TDG) , one the enzymes involved in the GADD45/deaminase/glycosylase pathway mentioned above.
Given that the DNA methylation status of certain genes in T cells changes rapidly following cell activation and that differentiation leads to significant shifts in the gene expression profile, we have examined the changes that occur in DNA methylation at both the gene-specific and genome-wide level following activation and differentiation and have attempted to correlate this with changes in the enzymes known to be involved in DNA methylation and active demethylation.
Global DNA demethylation occurs during T helper cell activation and differentiation into specific cell subsets
To examine the global changes in DNA methylation during T cell activation and differentiation, CD4+ T cells isolated from young and adult mice were examined immediately following their activation and again following differentiation into T helper cell subsets. McrBC endonuclease was used to cleave the methylated genomic DNA at loci where pairs of (A/G)MeC were located between 40 and 3000 bp apart (MeC is methyl-cytosine on one or both strands of DNA).
It has been shown that the developmental process leads to a change in the composition of the CD4+ T cell population with an increase in the proportion of memory/effector T cells [50, 51]. As seen in the FACS analysis (Additional file 1: Figure S1A, B), a shift from naive T cells to larger memory and effector T cell subset populations was observed during developmental progression. Naive T cells (CD44-CD62L+) were estimated at 90% (Additional file 1: Figure S1A) in the young mice but decreased to 64% in the adult mice (Additional file 1: Figure S1B), while effector/memory T cells (CD44+CD62L+/-) conversely increased from 4% to around 23% (Additional file 1: Figure S1A, B). We speculated that the difference in global DNA methylation levels between young and adult T cells detected in the McrBC assay might be related to the increase in memory and effector T cell populations in the older mice.
To confirm whether the change in DNA methylation levels was indeed related to the change in T cell subset populations, we performed similar McrBC experiments with FACS-sorted naive T cells isolated from both age groups. The cleavage products from McrBC endonuclease digestion showed a similar size distribution in both 2 week and 16 week naive T cells DNA (Figure 1B), indicating that genomic DNA isolated from naive T cells of both age groups had similar DNA methylation levels. Thus, the change in the proportion of memory/effector to naive T cells as mice age is likely contributing to the overall change in DNA methylation in the CD4+ T cell population.
To determine whether differentiation of CD4+ T cells in vitro leads to changes in the global DNA methylation, FACS-sorted naive T cells were stimulated under different polarising conditions using the appropriate cytokine combinations to generate specific T helper cell populations including Th1, Th2, Th17 and iTreg cells. The expression of genes specific for each of these T cell subsets was validated in each subset (Additional file 2) before the McrBC assay was used to determine global DNA methylation levels (Figure 1C). nTreg cells were also isolated from mouse spleens and the expression of Foxp3 used as a validation gene (Additional file 2). Interestingly, DNA demethylation occurred in all the differentiated T cell types, as judged by the fact that the digested products were significantly longer in the differentiated T cells after McrBC digestion compared with undifferentiated CD4+ T cells. Thus, we conclude that global DNA demethylation is a common phenotype occurring during T cell differentiation.
Overall, it was observed that the degree of genome methylation declined significantly following T cell activation and differentiation. Naive T cells, therefore, appear to display a more hypermethylated phenotype while activated, differentiated or memory/effector T cells display a more hypomethylated phenotype.
Our previous studies showed that chromatin structure is altered after T cell activation and becomes more accessible in specific genomic regions linked to genes that respond to activation [27, 52, 53]. To determine whether chromatin accessibility changed with T cell development, CD4+ T cells were isolated from both age groups of mice and digested with micrococcal nuclease (MNase). As expected, digestion with MNase produced nucleosomal ladders for both samples. Interestingly, an additional amount of micrococcal nuclease was required to digest the chromatin to mono- and di-nucleosomes in young mice (>100 units, Figure 1D), while a lesser amount of MNase was required for the adult mice (60 units, Figure 1F). This observation suggested that the global chromatin structure in the young mice was more compacted and less accessible to MNase. This compacted chromatin structure in the young mice correlates with the higher level of global DNA methylation (Figure 1A). Such compaction and hypermethylation in young T cells may be essential to maintaining inducible genes in an inactivated state in resting naive cells.
DNA demethylation occurs in the promoters of the Il2 and Csf2 genes following CD4+ T cell activation
Following stimulation by PMA/I, a shift from naive T cells to larger memory and effector T cell subset populations was observed as seen in the FACS analysis (Additional file 1: Figure S1C, D). Il2 and Csf2 mRNA expression increased significantly in both age groups, although the fold change relative to the unstimulated T cells was more pronounced in the younger mice (40000-fold in young mice compared to 800-fold in adult mice for Il2, and 103-fold in young mice compared to 62-fold in adult mice for Csf2 at 4 hours post stimulation) (Additional file 3: Figure S3B, C). We next examined the relative changes in DNA methylation at the CG dinucleotides located at the promoters of the Il2 and Csf2 genes in response to cell stimulation (Figure 2C-F). During PMA/I stimulation, DNA methylation levels consistently decreased across the promoter regions of both inducible genes in the two age groups. However, the decrease in DNA methylation was not as rapid in the adult mice, at least for some of the primer sets, compared to the younger mice (Figure 2C-F). The rapid and dynamic decreases in DNA methylation in the regions examined are consistent with the global DNA demethylation observed in response to PMA/I stimulation in both age groups observed earlier (Figure 1A), and also correlate with the significant increases in mRNA expression of Il2 and Csf2 in the activated cells. These results support the previous study in a transgenic T cell model in which rapid DNA demethylation was observed at the Il2 promoter .
Thus, although rapid DNA demethylation in the Il2 and Csf2 promoter regions correlates with the observed increase in gene expression when T cells are activated, the difference in gene expression between young and adult T cells is not accompanied by a corresponding change in promoter DNA methylation.
Chromatin accessibility at the Il2 and Csf2 promoters changes with age
Similar to our previous studies [53, 56], CD4+ T cell activation by PMA/I resulted in higher MNase accessibility, which was particularly pronounced at primer sets A of both the Il2 and Csf2 promoters in the young mice (Figure 3B, C). The regions assayed by primer set F located 2 kb upstream of the TSS of the Il2 gene and primer set B located outside the core Csf2 promoter showed little change in MNase accessibility following activation in both age groups as expected from our previous studies. Most importantly, the lack of change in accessibility at primer sets A of the Il2 and Csf2 genes following activation of adult mice T cells may reflect a more open chromatin structure (Figure 3B, C) and the smaller fold change in gene expression may be due to the relatively higher basal levels of gene expression (Additional file 3: Figure S3B, C).
Promoter chromatin accessibility, therefore, correlates with gene expression levels whether during T cell development or following activation.
DNA demethylation at individual gene promoters during T cell differentiation
These results indicate that although there is a significant change in overall or genomic DNA methylation as cells differentiate into T helper cell subtypes, there is also a level of specificity for demethylation at specific gene promoters.
Changes in DNA methylating and demethylating enzymes in T cells
DNA methylation and demethylation are two opposing epigenetic processes involved in genome regulation and are modulated by various enzymes as described above. Since we observed changes in both global and gene-specific DNA methylation during T cell activation and differentiation, we were interested in determining whether the enzymatic mechanisms involved in these processes were also altered. Thus we investigated the mRNA expression of genes involved in the DNA methylation and demethylation pathways, including three DNMTs, the deaminase/glycosylase/GADD45 complex and the TET enzymes, following T cell activation and differentiation.
Interestingly, when we examined mRNA expression of the TET proteins in response to PMA/I activation, a greater than 7-fold increase was detected for Tet2 mRNA in both age groups (Figure 6C) suggesting that TET2 may be involved in DNA demethylation during T cell activation.
When we examined expression of the TET genes, Tet2 was the only gene that showed a greater than a 2-fold increase in mRNA expression in all the differentiated T cells (Figure 7C). In addition, there was a greater than 10-fold increase in Tet1 expression in both Th1 and Th2 cells (Figure 7C), suggesting that both TET1 and TET2 may be involved in DNA demethylation during T cell differentiation processes.
Overall, our data revealed that enzymes involved in the two opposing epigenetic processes were dramatically altered during T cell activation and differentiation. GADD45 proteins along with deaminases, glycosylases and the TET proteins were significantly up-regulated in response to T cell activation and differentiation, while changes (generally decreases) were also observed for the DNA methyltransferases.
5-hydroxymethylcytidine is detected at gene promoters following T cell activation and differentiation
Thus, changes in 5hmC levels accompany changes in gene expression during T cell activation and differentiation and, together with the data showing a corresponding increase in expression of the Tet genes, suggest that the generation of 5hmC may be part of the mechanism of demethylation.
The results presented in this paper show that DNA methylation is dynamic in mouse T cells with distinct DNA methylation levels observed in different CD4+ T cell populations. Following T cell activation, demethylation of DNA occurs rapidly with a major global shift observed within hours of stimulation. In addition, all the differentiated T cell types examined, including regulatory T cells, appear to have a more hypomethylated phenotype than their non-differentiated counterparts. CD4+ T cells from older mice also display a hypomethylated phenotype but this appears to be related to the altered cellular composition of the older T cell population with a greater percentage of the cells being effector/memory type cells. These results are in agreement with many recent observations showing that DNA methylation is more dynamic than previously considered [10–12, 14, 63, 64] and that changes in DNA methylation are not always linked to DNA replication . DNA demethylation can occur in response to extracellular signals, during embryonic development and during tissue differentiation [5, 14]. These changes in DNA methylation have been documented both at the global genome-wide level and at individual genes. For example, in experiments fusing human fibroblasts and mouse muscle cells to form non-dividing heterokaryons, active DNA demethylation and subsequent expression of the Myod1 gene was observed . Active DNA demethylation, independent of cell division, has also been observed on the paternal genome but not the maternal genome following fertilisation [66, 67]. Active DNA demethylation has also been demonstrated in post-mitotic neurons at the promoters of brain-derived neurotrophic factor (Bdnf) and fibroblast growth factor-1 (Fgf1) .
In this study, analysis of individual genes demonstrated that following T cell activation, there was very rapid demethylation at both the Il2 and Csf2 promoters, two genes whose expression is rapidly induced following activation. These results are in agreement with a previous study of the Il2 gene in a TCR transgenic mouse model  which clearly demonstrated that the demethylation observed at the Il2 promoter following T cell activation was rapid and independent of DNA replication. In addition, our results show that the rapid loss of 5-methylcytosine is accompanied by an increase in 5-hydroxymethycytosine at the promoter of both genes implying a role for the TET family [11, 14] in an active mechanism of demethylation. This activation-dependent demethylation was observed in T cells from both young and adult mice although the degree and timing differed in the two groups.
Older T cells express more Il2 and Csf2 in the resting state than younger T cells, most likely due to the increased percentage of the population that has an effector/memory phenotype. Decreased expression of the methyltransferases, DNMT1 and DNMT3a, has been associated with increased gene expression in T cells during aging  and we also observed a significant decrease in these enzymes in older T cells. We also show here that the mRNA expression of several proteins implicated in DNA demethylation is increased in the older T cell population. Although there was a strong difference in global DNA methylation levels between younger and older T cells, in parallel with the changes in the expression of the methylating and demethylating enzymes, we detected only small differences between these cell populations at the Il2 or Csf2 promoters. We attribute this to the sensitivity of the assay since the naive cell population dominated the total CD4+ T cell population. We also detected small differences in chromatin accessibility suggesting that these two genes were more active in the older population, an observation borne out by the increases observed in the mRNA levels. It is likely that these increases in mRNA are the result of increased expression in only a fraction of the total population being examined thus leading to difficulties in detecting changes in DNA methylation and chromatin accessibility in the total population.
Although we observed large changes in the global level of DNA methylation following T cell differentiation, we also observed a significant degree of specificity when individual genes were examined. For example, the Il4 promoter was demethylated in Th2 but not Th1 cells as has been previously demonstrated . The differentiation of Th17 and Treg cells has been linked through a common TGFβ signalling pathway in which transcription factors such as RORγt and FOXP3 interact in a competitive antagonism and drive commitment towards the Th17 or Treg lineages respectively . We observed a clear distinction in the demethylation patterns of the Th17-specific Il17 promoter and the Treg-specific Foxp3 promoter with the most significant demethylation observed in the cells that express these genes. These results imply that targeted demethylation occurs on specific genes expressed in, and linked to the function of these cell types. There is evidence that recruitment of DNA methyltransferases to specific genes may change upon T cell differentiation . Under Th2 polarising conditions, DNA demethylation at Il4 and Il13 is initiated through reduced DNMT1 recruitment and an increase in active histone H3K4 methylation markers at this locus . FOXP3 is a master transcription factor required for the development and function of Treg cells and the DNA methyltransferases, DNMT1 and DNMT3A, have been shown to be associated with the Foxp3 locus in CD4+ T cells, resulting in repression of Foxp3 expression . Recruitment of the opposing DNA demethylase complexes will now need to be examined.
Although enzymes involved in DNA methylation have long been known, a mechanism to explain active DNA demethylation has only recently been described [11, 12, 14]. A plethora of recent studies has demonstrated two, possibly interlinked, mechanisms of active DNA demethylation as described earlier . Here, we examined the expression of the various enzymatic and non-enzymatic components of these DNA demethylating complexes, in addition to the well-described DNA methylation enzymes, to ask if there was a correlation between DNA methylation levels and the expression of these opposing enzymatic activities. We detected the expression of Dnmt1, Dnmt3a and Dnmt3b in CD4+ T cells and found that expression was decreased in older T cells and in all differentiated T cell types in parallel with the globally hypomethylated phenotype. In parallel with the decrease in DNA methylating enzymes observed in differentiated T cells compared with their non-differentiated counterparts, we found increased mRNA expression of various members of the AICDA/APOBEC/glycosylase and TET families of demethylating enzymes. Of particular note is the strong increase observed for the Tet1 and Tet2 proteins in Th1 and Th2 cells and the accompanying increase in 5hmC at the promoters of the Ifng and Il4 genes in Th1 and Th2 cells respectively. The Foxp3 gene promoter also displayed a clear increase in 5hmC in both nTreg and iTreg cells although this was associated with a smaller increase in expression of the TET family members in these cell types. Each differentiated cell type appears have a distinct profile of expression of the AICDA/APOBEC/glycosylase family members as well as the GADD45 scaffold proteins suggesting that each cell type may use distinct demethylating complex(es) to achieve a more hypomethylated state.
Examination of the expression of the DNA demethylating complexes clearly showed that T cell activation led to an increase in the expression of several components of the AICDA/APOBEC complex, in particular, Apobec3 and Apobec4, as well as the DNA glycosylase Tdg. The expression of Tet2, a member of the TET family that can hydroxylate 5mC to 5hmC was also increased following T cell activation and as discussed above, there was an increase in 5hmC observed at the promoters of both the Il2 and Csf2 genes. Members of the GADD45 family have been implicated in the function of the AICDA/APOBEC family by acting as a scaffold protein to coordinate the deamination and glycosylase functions . GADD45 proteins have long been implicated in immune function [71–75] and the expression of Gadd45b increased following cell activation as in the previous studies [74, 75]. Dnmt3a expression increased immediately following T cell activation, an unexpected result given the observed decrease in DNA methylation following activation. However the expression of Dnmt3a subsequently decreased after stimulation for 8 h (data not shown). Nevertheless, two clear points emerge from these studies. Firstly, when T cells are activated, differentiate or age (and hence change in cellular composition) there is a shift in the balance of expression of the DNA methylating and demethylating enzymes accompanied by a shift in the global methylation status of the DNA. Secondly, these activities must be targeted to specific genomic regions or genes whose expression changes during these processes and further studies need to be done to determine the targeting mechanisms.
DNA demethylation has been linked to autoimmunity, in particular to systemic lupus erythematosus (SLE). CD4+ T cells from SLE patients have been shown to have significantly lower DNA 5mC content than T cells from controls [76, 77] and mouse CD4+ T cells treated with a methylation inhibitor and transferred to syngeneic mice induce symptoms of SLE . The expression of specific genes, such as perforin, is increased in CD4+ lupus cells and this is accompanied by hypomethylation at their promoters . However, there has not been a clear demonstration of a decrease in the expression of the DNA methylating enzymes despite several studies [36, 79]. A recent study, however, showed that GADD45a may contribute to autoimmunity by promoting DNA demethylation in lupus T cells . This work raises the possibility that the active DNA demethylating enzyme complexes such as AICDA/APOBEC and the TET family may be associated with autoimmunity and warrants further investigation.
In summary, we have demonstrated that DNA methylation is dynamic and flexible in CD4+ T cells and changes rapidly both in a genome-wide and in a targeted manner during T cell activation and differentiation. These changes are accompanied by parallel changes in the enzymatic complexes that have been implicated in DNA methylation and demethylation implying that the balance between these opposing activities may play a role in the maintaining the methylation profile of a given cell type and also allow flexibility in a cell population that needs to respond rapidly to environmental signals.
Materials and methods
Animals and ethics
Male C57BL/6 mice (Animal Resources Centre (ARC)) were housed in a room at constant temperature (22 ± 1°C) with a 12-hour alternating light dark cycle (6:00-18:00), and given free access to commercially-produced mouse feed and tap water. This study was approved by the Animal Experimental Ethics Committee of the Australian National University (Animal Ethics Project Numbers J.MB.45.09 and J.MB.51.10).
Cell culture and stimulation
Spleens were isolated from C57BL/6 mice (2 and 16 weeks old). CD4+ T cells were purified in MLC medium using MACS CD4+ (LT34) beads according to the manufacturer's guidelines (Miltenyi Biotec, Bergisch Gladbach, Germany). Pure CD4+ T cells were cultured in completed MLC with 10% fetal bovine serum (FBS), 10 mM HEPES, 4 mM glutamine, 1 mM sodium pyruvate, 1.76 μL β-mercaptoethanol and antibiotics.
The CD4+ T cells were stimulated by addition of phorbol 12-myristate 13-acetate (PMA) (10 ng/mL) and calcium ionophore (I) (1 μM). Cells were incubated inside a standard CO2 incubator at 37°C with 5% CO2.
Th1 and Th2 cells
Naive T cells were initially isolated from C57BL/6 mice spleens (ARC, 7 weeks old), followed by sorting with flow cytometry using CD4+ and CD62L+ as selective markers. The sorted naive T cells were cultured initially in MLC medium supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin, and 50 μM β-mercaptoethanol (all from Sigma-Aldrich). For generation of Th1 or Th2 cells, 0.25 × 106 cell/mL naive T cells were cultured on anti-CD3 (2 μg/mL) and anti-CD28 (2 μg/mL) coated 24-well plates in the presence of either 10 ng/mL IL12 (R&D Systems), 10 μg/mL anti-IL4 (1B11) blocking antibodies for the Th1 condition; or 10 ng/mL IL4 (R&D Systems), 10 μg/mL anti-IL12 (p40/p70), 10 μg/mL anti-IFNg blocking antibodies for the Th2 condition. Both Th1 and Th2 cells were cultured under their corresponding conditions for a maximum of 8 days inside a standard CO2 incubator at 37°C with 5% CO2, with medium changed every two days. IL4 and IFNg production in the induced CD4+ T cells were determined by intracellular cytokine staining as described later. Th1 and Th2 differentiated T cells were further enriched by FACS with CD4+IFNghi and CD4+IL4hi as selective markers, respectively (Additional file 4: Figure S4A, B).
Th17 cell polarization
Naive T cells (CD4+CD62L+) sorted by flow cytometry from 7 week old C57BL/6 mice spleens were cultured in MLC medium supplemented (detailed in Th1 and Th2 above), under Th17 polarising conditions with 10 μg/mL CD3e, 5 μg/mL CD28, 10 ng/mL IL6 (all from BD), and 1 ng/mL TGFβ as stimuli. All these reagents were directly added to the cells, without prior coating in 50 mL flasks. After stimulation for 4 days inside a standard CO2 incubator at 37°C with 5% CO2, cells were harvested and washed at least three times with cold 2% BSA-PBS. Th17 cells were captured with IL17 capture kit (BD) according to the manufacturer's instructions and the methods published previously [80, 81]. Briefly, cells were incubated with 2 aliquots of IL17A capture complex (BD) in 500 μL cold medium at a maximum density of 8 × 106/mL on ice for 10 min. Warm medium (40 mL, 37°C) was added and the mixture was incubated and gently mixed intermittently for an additional 1.5 hours at 37°C. After cytokine capture, extra cold 2% BSA-PBS was added and placed on ice for 15 min. Cells were spun down and washed twice before staining with PE-conjugated anti-IL17A followed by cell sorting. Cell viability was determined by trypan blue exclusion and was always greater than 90% after isolation (Additional file 4: Figure S4C).
Natural Treg (nTreg) cells
Natural Treg cells (CD4+ CD25+ ) were sorted by flow cytometry from 7 week old C57BL/6 mice spleens (Additional file 4: Figure S4D).
Induced Treg (iTreg) cells
For generation of iTreg cells, naive T cells (CD4+CD25-) sorted by flow cytometry from 7 week old male C57BL/6 mice spleens, were stimulated with anti-CD3 (6 μg/mL) and anti-CD28 (4 μg/mL) coated 6-well plates in the presence of either 10 ng/mL IL2 (R&D Systems) or 5 ng/mL human TGFβ1 (R&D Systems) for 4 days, and in MLC medium supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin, and 50 μM mercaptoethanol (all from Sigma-Aldrich). FOXP3 production in total CD4+ T cells was determined by intracellular cytokine staining as described below. iTreg differentiated T cells were further enriched by FACS with CD4+ and CD25+ as selective markers (Additional file 4: Figure S4E).
CD4+ T cells (at least 50,000 cells) were incubated with antibodies (1:200 dilution) in 200 μL PBS containing 2% BSA for 15-30 min at 4°C. Cell pellets were resuspended in 200 μL PBS containing 0.5% BSA and kept on ice until FACS.
GolgiStop (0.7 μL/mL) was added to the stimulated CD4+ T cells. The cells were first stained with FITC-CD4 (1:400) in PBS containing 2% BSA buffer on ice for 30 min, and then fixed in 200 μL permeabilization buffer for 30 min on ice. Stained cells were then washed twice with 200 μL of the same buffer, before incubating with CD16/CD32 (1:400) and 200 μL permeabilization buffers for 30 min on ice. The cells were finally stained with PE-IFNg, PE-IL4 or PE-IL17A for 30 min on ice, washed once with 200 μL permeabilization buffer, and twice with PBS containing 2% BSA.
cDNA Synthesis and Real time-PCR
Total RNA was prepared from stimulated and unstimulated T cells using TriReagent (Sigma-Aldrich) according to the manufacturer's instructions. RNA (1 μg) was treated with DNase I (1 U) in Tris buffer (pH 7.6) containing 5 mM MgCl2 at 37°C for 30 min, and reverse-transcribed using first-strand cDNA synthesis (Marligen, Ljamsville, USA) as detailed in the manufacturer's instructions. Real-time PCR reactions were performed with 50 ng of cDNA and Power SYBR® Green PCR Master Mix (ABI) in a total volume of 20 μL on an ABI 7500 sequence detector (Applied Biosystems). Details of the primers used for gene expression are listed in Additional file 5. The Ct values for the genes of interest were normalized to the housekeeping gene, Ubiquitin-conjugating enzyme E2D (Ubc), whose expression was not altered in response to PMA/I stimulation. The following PCR conditions were used: stage 1, 50°C for 2 min for one cycle; stage 2, 95°C for 10 min for one cycle; and stage 3, 95°C for 15 sec and 60°C for 1 min for 40 cycles.
Genomic DNA from CD4 T cells was extracted using a QIAamp DNA Blood Mini Kit (Qiagen) based on the manufacturer's protocol. Genomic DNA (1 μg) was digested with McrBC (10 units) endonuclease (NEB) in the presence of 10 mM GTP and NEBuffer 2. The sample was incubated at 37°C for 6 hours prior to loading onto a 1% agarose gel. After staining with ethidium bromide, gel images were taken with a Gene Genius Bio Imaging system (Syngene).
Genomic DNA from CD4 T cells was extracted using a QIAamp DNA Blood Mini Kit (Qiagen). For MeDIP, gDNA (2 μg) was sonicated in an ice bath for 20 min at 4°C until average DNA fragments were in the range of 500 to 1000 bp. gDNA samples were denatured at 90°C for 10 min before incubation with 2 μg 5-methylcytosine antibody (Epigentek, 33D3) in IP buffer (100 mM sodium phosphate, pH 7.0, 1.4 M NaCl and 0.5% Triton X-100) for at least 1 hour at 4°C. Dynabeads® Sheep-anti Mouse IgG (Invitrogen, 20 μL, pre-washed with PBS-BSA 0.1%) was incubated with the gDNA/5-methylcytosine antibody mixture for an additional 1 hour at 4°C. The Dynabeads were then collected on a magnetic rack, washed with IP buffer three times and TE buffer once, before resuspension in proteinase K digestion buffer (50 mM Tris, pH 8.0, 10 mM EDTA and 0.5% SDS) and 100 mg proteinase K and incubated at 65°C for 1 hour. Enriched methylated DNA fragments were further purified from the final mixture using PCR purification kits (Invitrogen). Real-time PCR reactions were performed with the enriched DNA fragments and Power SYBR® Green PCR Master Mix (ABI) in a total volume of 20 μL on an ABI 7500 sequence detector (Applied Biosystems). Details of the primers used for the gene expression are listed in Additional file 6.
Cell pellets (5 × 107 cells) were resuspended gently in 10 mL buffer A (10 mM Tris, PH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.1 mM EDTA, 0.5% NP-40, 0.2 mM Pefabloc SC and complete protease inhibitor cocktail (Roche)), and incubated on ice for 5 min. After centrifugation at 1800 rpm for 5 min at 4°C, supernatant (cytoplasm extract) was carefully removed. Nuclei pellets were washed once with MNase buffer (10 mM Tris, PH 7.5, 15 mM NaCl, 60 mM KCl, 0.15 mM spermine and 0.5 mM spermidine), and nuclei resuspended in the same buffer (at a density of 5 × 106 per 94 μL MNase buffer). MNase digestion was carried out in the presence of 2 mM CaCl2 and 50 U of MNase (micrococcal nuclease, NEB) for 10 min or the desired digestion time at 37°C. The reaction was stopped by the addition of 20 mL termination buffer. A QIAamp DNA blood kit (Qiagen) was used immediately after the MNase digestion for DNA isolation. The MNase digested samples were either subjected to gel electrophoresis (1% agarose gel) or quantitative real-time PCR. Real-time PCR were carried out by using primers of interest and Power SYBR® Green PCR Master Mix (ABI). The primer sequences were designed against both the promoter regions and 1 kb up-stream of the gene TSS, and are listed in Additional file 6. DNA accessibility was calculated based on a method described previously .
Data were expressed as mean ± SEM of at least three independent experiments. Statistical significance was computed by One Way ANOVA (SPSS 17.0). A p < 0.05 was considered statistically significant.
phorbol 12-myristate 13-acetate and calcium ionophore
fluorescent-activated cell sorting
immunoprecipitation of methylated DNA
granulocyte-macrophage colony-stimulating factor
apolipoprotein B-editing catalytic
growth arrest and DNA-damage-inducible 45
This work was supported by an NHMRC project grant (ID 418048) and funded by an Epigenomics Capacity Development grant from Bioplatforms Australia to MFS. This research was also supported by a National Science Foundation of China Grant (No. 31172185) to CS. A scholarship from the Chinese Scholarship Council was awarded to YL.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- Holliday R: The inheritance of epigenetic defects. Science. 1987, 238: 163-170. 10.1126/science.3310230View ArticlePubMedGoogle Scholar
- Morgan HD, Santos F, Green K, Dean W, Reik W: Epigenetic reprogramming in mammals. Hum Mol Genet. 2005, 14: R47-R58. 10.1093/hmg/ddi114View ArticlePubMedGoogle Scholar
- Feng S, Jacobsen SE, Reik W: Epigenetic Reprogramming in Plant and Animal Development. Science. 2010, 330: 622-627. 10.1126/science.1190614View ArticlePubMedPubMed CentralGoogle Scholar
- Reik W, Dean W, Walter J: Epigenetic reprogramming in mammalian development. Science. 2001, 293: 1089-1093. 10.1126/science.1063443View ArticlePubMedGoogle Scholar
- Calvanese V, Fernández AF, Urdinguio RG, Suárez-Alvarez B, Mangas C, Pérez-García V, Bueno C, Montes R, Ramos-Mejía V, Martínez-Camblor P, et al.: A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res. 2012, 40: 116-131. 10.1093/nar/gkr685View ArticlePubMedPubMed CentralGoogle Scholar
- Deaton AM, Webb S, Kerr ARW, Illingworth RS, Guy J, Andrews R, Bird A: Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res. 2011, 21: 1074-1086. 10.1101/gr.118703.110View ArticlePubMedPubMed CentralGoogle Scholar
- Nishino K, Toyoda M, Yamazaki-Inoue M, Fukawatase Y, Chikazawa E, Sakaguchi H, Akutsu H, Umezawa A: DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time. PLoS Genet. 2011, 7: e1002085- 10.1371/journal.pgen.1002085View ArticlePubMedPubMed CentralGoogle Scholar
- Bocker MT, Hellwig I, Breiling A, Eckstein V, Ho AD, Lyko F: Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood. 2011, 117: e182-e189. 10.1182/blood-2011-01-331926View ArticlePubMedGoogle Scholar
- Schmidl C, Klug M, Boeld TJ, Andreesen R, Hoffmann P, Edinger M, Rehli M: Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res. 2009, 19: 1165-1174. 10.1101/gr.091470.109View ArticlePubMedPubMed CentralGoogle Scholar
- Shearstone JR, Pop R, Bock C, Boyle P, Meissner A, Socolovsky M: Global DNA demethylation during mouse erythropoiesis in vivo. Science. 2011, 334: 799-802. 10.1126/science.1207306View ArticlePubMedPubMed CentralGoogle Scholar
- Wu SC, Zhang Y: Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol. 2010, 11: 607-620. 10.1038/nrm2950View ArticlePubMedPubMed CentralGoogle Scholar
- Zhu J-K: Active DNA Demethylation Mediated by DNA Glycosylases. Annu Rev Genet. 2009, 43: 143-166. 10.1146/annurev-genet-102108-134205View ArticlePubMedPubMed CentralGoogle Scholar
- Cortellino S, Xu J, Sannai M, Moore R, Caretti E, Cigliano A, Le Coz M, Devarajan K, Wessels A, Soprano D, et al.: Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair. Cell. 2011, 146: 67-79. 10.1016/j.cell.2011.06.020View ArticlePubMedPubMed CentralGoogle Scholar
- Bhutani N, Burns DM, Blau HM: DNA Demethylation Dynamics. Cell. 2011, 146: 866-872. 10.1016/j.cell.2011.08.042View ArticlePubMedPubMed CentralGoogle Scholar
- Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008, 454: 5-Google Scholar
- Ji H, Ehrlich LIR, Seita J, Murakami P, Doi A, Lindau P, Lee H, Aryee MJ, Irizarry RA, Kim K, et al.: Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature. 2010, 467: 338-342. 10.1038/nature09367View ArticlePubMedPubMed CentralGoogle Scholar
- Grubeck-Loebenstein B, Wick G: The aging of the immune system. Adv Immunol. 2002, 80: 243-284.View ArticlePubMedGoogle Scholar
- Kovaiou RD, Grubeck-Loebenstein B: Age-associated changes within CD4+ T cells. Immunol Lett. 2006, 107: 8-14. 10.1016/j.imlet.2006.07.006View ArticlePubMedGoogle Scholar
- Agarwal S, Rao A: Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity. 1998, 9: 765-775. 10.1016/S1074-7613(00)80642-1View ArticlePubMedGoogle Scholar
- Bix M, Locksley RM: Independent and Epigenetic Regulation of the Interleukin-4 Alleles in CD4+ T Cells. Science. 1998, 281: 1352-1354.View ArticlePubMedGoogle Scholar
- Lal G, Zhang N, van der Touw W, Ding Y, Ju W, Bottinger EP, Reid SP, Levy DE, Bromberg JS: Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol. 2009, 182: 259-273.View ArticlePubMedPubMed CentralGoogle Scholar
- Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, et al.: Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007, 5: e38- 10.1371/journal.pbio.0050038View ArticlePubMedPubMed CentralGoogle Scholar
- Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, Thiel A, Boeld TJ, Hoffmann P, Edinger M, et al.: DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol. 2007, 37: 2378-2389. 10.1002/eji.200737594View ArticlePubMedGoogle Scholar
- Nagar M, Vernitsky H, Cohen Y, Dominissini D, Berkun Y, Rechavi G, Amariglio N, Goldstein I: Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells. Int Immunol. 2008, 20: 1041-1055. 10.1093/intimm/dxn062View ArticlePubMedGoogle Scholar
- Kim H-P, Leonard WJ: CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med. 2007, 204: 1543-1551.View ArticlePubMedPubMed CentralGoogle Scholar
- Guan H, Nagarkatti PS, Nagarkatti M: CD44 Reciprocally Regulates the Differentiation of Encephalitogenic Th1/Th17 and Th2/Regulatory T Cells through Epigenetic Modulation Involving DNA Methylation of Cytokine Gene Promoters, Thereby Controlling the Development of Experimental Autoimmune Encephalomyelitis. J Immunol. 2011, 186: 6955-6964. 10.4049/jimmunol.1004043View ArticlePubMedPubMed CentralGoogle Scholar
- Chen X, Wang J, Woltring D, Gerondakis S, Shannon MF: Histone dynamics on the interleukin-2 gene in response to T-cell activation. Mol Cell Biol. 2005, 25: 3209-3219. 10.1128/MCB.25.8.3209-3219.2005View ArticlePubMedPubMed CentralGoogle Scholar
- Bruniquel D, Schwartz RH: Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol. 2003, 4: 235-240. 10.1038/ni887View ArticlePubMedGoogle Scholar
- Murayama A, Sakura K, Nakama M, Yasuzawa-Tanaka K, Fujita E, Tateishi Y, Wang Y, Ushijima T, Baba T, Shibuya K, et al.: A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J. 2006, 25: 1081-1092. 10.1038/sj.emboj.7601012View ArticlePubMedPubMed CentralGoogle Scholar
- Oakes CC, Smiraglia DJ, Plass C, Trasler JM, Robaire B: Aging results in hypermethylation of ribosomal DNA in sperm and liver of male rats. Proc Natl Acad Sci USA. 2003, 100: 1775-1780. 10.1073/pnas.0437971100View ArticlePubMedPubMed CentralGoogle Scholar
- Calvanese V, Lara E, Kahn A, Fraga MF: The role of epigenetics in aging and age-related diseases. Ageing Res Rev. 2009, 8: 268-276. 10.1016/j.arr.2009.03.004View ArticlePubMedGoogle Scholar
- So K, Tamura G, Honda T, Homma N, Waki T, Togawa N, Nishizuka S, Motoyama T: Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci. 2006, 97: 1155-1158. 10.1111/j.1349-7006.2006.00302.xView ArticlePubMedGoogle Scholar
- Jintaridth P, Mutirangura A: Distinctive patterns of age-dependent hypomethylation in interspersed repetitive sequences. Physiol Genomics. 2010, 41: 194-200. 10.1152/physiolgenomics.00146.2009. 10.1152/physiolgenomics.00146.2009View ArticlePubMedGoogle Scholar
- Whisler RL, Beiqing L, Chen M: Age-Related Decreases in IL-2 Production by Human T Cells Are Associated with Impaired Activation of Nuclear Transcriptional Factors AP-1 and NF-AT. Cell Immunol. 1996, 169: 185-195. 10.1006/cimm.1996.0109View ArticlePubMedGoogle Scholar
- Haynes L, Linton P-J, Eaton SM, Tonkonogy SL, Swain SL: Interleukin 2, but Not Other Common γ Chain-Binding Cytokines, Can Reverse the Defect in Generation of Cd4 Effector T Cells from Naive T Cells of Aged Mice. J Exp Med. 1999, 190: 1013-1024. 10.1084/jem.190.7.1013View ArticlePubMedPubMed CentralGoogle Scholar
- Zhang Z, Deng C, Lu Q, Richardson B: Age-dependent DNA methylation changes in the ITGAL (CD11a) promoter. Mech Ageing Dev. 2002, 123: 1257-1268. 10.1016/S0047-6374(02)00014-3View ArticlePubMedGoogle Scholar
- Kersh EN, Fitzpatrick DR, Murali-Krishna K, Shires J, Speck SH, Boss JM, Ahmed R: Rapid Demethylation of the IFN-gamma Gene Occurs in Memory but Not Naive CD8 T Cells. J Immunol. 2006, 176: 4083-4093.View ArticlePubMedGoogle Scholar
- Northrop JK, Thomas RM, Wells AD, Shen H: Epigenetic Remodeling of the IL-2 and IFN-gamma Loci in Memory CD8 T Cells Is Influenced by CD4 T Cells. J Immunol. 2006, 177: 1062-1069.View ArticlePubMedGoogle Scholar
- Jones PA, Liang G: Rethinking how DNA methylation patterns are maintained. Nat Rev Genet. 2009, 10: 805-811.View ArticlePubMedPubMed CentralGoogle Scholar
- Robert M-F, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR: DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet. 2003, 33: 61-65. 10.1038/ng1068View ArticlePubMedGoogle Scholar
- Bird A: DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16: 6-21. 10.1101/gad.947102View ArticlePubMedGoogle Scholar
- Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK: Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J Biol Chem. 2004, 279: 52353-52360. 10.1074/jbc.M407695200View ArticlePubMedGoogle Scholar
- Rai K, Huggins IJ, James SR, Karpf AR, Jones DA, Cairns BR: DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell. 2008, 135: 1201-1212. 10.1016/j.cell.2008.11.042View ArticlePubMedPubMed CentralGoogle Scholar
- Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A: The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature. 1999, 401: 301-304. 10.1038/45843View ArticlePubMedGoogle Scholar
- Ma DK, Jang M-H, Guo JU, Kitabatake Y, M-l Chang, Pow-anpongkul N, Flavell RA, Lu B, G-l Ming, Song H: Neuronal Activity-Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis. Science. 2009, 323: 1074-1077. 10.1126/science.1166859View ArticlePubMedPubMed CentralGoogle Scholar
- Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y: Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010, 466: 1129-1133. 10.1038/nature09303View ArticlePubMedPubMed CentralGoogle Scholar
- Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al.: Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1. Science. 2009, 324: 930-935. 10.1126/science.1170116View ArticlePubMedPubMed CentralGoogle Scholar
- Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y: Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine. Science. 2011, 333: 1300-1303. 10.1126/science.1210597View ArticlePubMedPubMed CentralGoogle Scholar
- He Y-F, Li B-Z, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, et al.: Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA. Science. 2011, 333: 1303-1307. 10.1126/science.1210944View ArticlePubMedPubMed CentralGoogle Scholar
- Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint J-P, Labalette M: Accumulation of memory T cells from childhood to old age: Central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment. Mech Ageing Dev. 2006, 127: 274-281. 10.1016/j.mad.2005.11.001View ArticlePubMedGoogle Scholar
- Utsuyama M, Hirokawa K, Kurashima C, Fukayama M, Inamatsu T, Suzuki K, Hashimoto W, Sato K: Differential age-change in the numbers of CD4 + CD45RA + and CD4 + CD29+ T-cell subsets in human peripheral-blood. Mech Ageing Dev. 1992, 63: 57-68. 10.1016/0047-6374(92)90016-7View ArticlePubMedGoogle Scholar
- Rao S, Gerondakis S, Woltring D, Shannon MF: c-Rel Is Required for Chromatin Remodeling Across the IL-2 Gene Promoter. J Immunol. 2003, 170: 3724-3731.View ArticlePubMedGoogle Scholar
- Holloway AF, Rao S, Chen X, Shannon MF: Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins. J Exp Med. 2003, 197: 413-423. 10.1084/jem.20021039View ArticlePubMedPubMed CentralGoogle Scholar
- Mohn F, Weber M, Schubeler D, Roloff TC: Methylated DNA immunoprecipitation (MeDIP). Methods Mol Biol. 2009, 507: 55-64. 10.1007/978-1-59745-522-0_5View ArticlePubMedGoogle Scholar
- Vucic EA, Wilson IM, Campbell JM, Lam WL: Methylation Analysis by DNA Immunoprecipitation (MeDIP). Microarray Analysis of the Physical Genome: Methods and Protocols. Edited by: Pollack JR. 2009, 556: 141-153. 10.1007/978-1-60327-192-9_10.View ArticleGoogle Scholar
- Rao S, Procko E, Shannon MF: Chromatin Remodeling, Measured by a Novel Real-Time Polymerase Chain Reaction Assay, Across the Proximal Promoter Region of the IL-2 Gene. J Immunol. 2001, 167: 4494-4503.View ArticlePubMedGoogle Scholar
- Attema JL, Reeves R, Murray V, Levichkin I, Temple MD, Tremethick DJ, Shannon MF: The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation. J Immunol. 2002, 169: 2466-2476.View ArticlePubMedGoogle Scholar
- Attema JL, Reeves R, Murray V, Levichkin I, Temple MD, Tremethick DJ, Shannon MF: The Human IL-2 Gene Promoter Can Assemble a Positioned Nucleosome That Becomes Remodeled Upon T Cell Activation. J Immunol. 2002, 169: 2466-2476.View ArticlePubMedGoogle Scholar
- Santangelo S, Cousins DJ, Triantaphyllopoulos K, Staynov DZ: Chromatin structure and DNA methylation of the IL-4 gene in human T(H)2 cells. Chromosome Res. 2009, 17: 485-496. 10.1007/s10577-009-9040-3View ArticlePubMedGoogle Scholar
- Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, Wilson CB: Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol. 2003, 4: 1183-1190. 10.1038/ni1004View ArticlePubMedGoogle Scholar
- Winders BR, Schwartz RH, Bruniquel D: A Distinct Region of the Murine IFN-γ Promoter Is Hypomethylated from Early T Cell Development through Mature Naive and Th1 Cell Differentiation, but Is Hypermethylated in Th2 Cells. J Immunol. 2004, 173: 7377-7384.View ArticlePubMedGoogle Scholar
- Yano S, Ghosh P, Kusaba H, Buchholz M, Longo DL: Effect of promoter methylation on the regulation of IFN-gamma gene during in vitro differentiation of human peripheral blood T cells into a Th2 population. J Immunol. 2003, 171: 2510-2516.View ArticlePubMedGoogle Scholar
- Reik W: Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007, 447: 425-432. 10.1038/nature05918View ArticlePubMedGoogle Scholar
- Hernandez DG, Nalls MA, Gibbs JR, Arepalli S, van der Brug M, Chong S, Moore M, Longo DL, Cookson MR, Traynor BJ, et al.: Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet. 2011, 20: 1164-1172. 10.1093/hmg/ddq561View ArticlePubMedPubMed CentralGoogle Scholar
- Zhang F, Pomerantz JH, Sen G, Palermo AT, Blau HM: Active tissue-specific DNA demethylation conferred by somatic cell nuclei in stable heterokaryons. Proc Natl Acad Sci. 2007, 104: 4395-4400. 10.1073/pnas.0700181104View ArticlePubMedPubMed CentralGoogle Scholar
- Oswald J, Engemann S, Lane N, Mayer W, Olek A, Fundele R, Dean W, Reik W, Walter J: Active demethylation of the paternal genome in the mouse zygote. Curr Biol. 2000, 10: 475-478. 10.1016/S0960-9822(00)00448-6View ArticlePubMedGoogle Scholar
- Nakamura T, Arai Y, Umehara H, Masuhara M, Kimura T, Taniguchi H, Sekimoto T, Ikawa M, Yoneda Y, Okabe M, et al.: PGC7/Stella protects against DNA demethylation in early embryogenesis. Nat Cell Biol. 2007, 9: 64-71. 10.1038/ncb1519View ArticlePubMedGoogle Scholar
- Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE: DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation. Science. 2003, 302: 890-893. 10.1126/science.1090842View ArticlePubMedGoogle Scholar
- Lee YK, Mukasa R, Hatton RD, Weaver CT: Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol. 2009, 21: 274-280. 10.1016/j.coi.2009.05.021View ArticlePubMedGoogle Scholar
- Lal G, Bromberg JS: Epigenetic mechanisms of regulation of Foxp3 expression. Blood. 2009, 114: 3727-3735. 10.1182/blood-2009-05-219584View ArticlePubMedPubMed CentralGoogle Scholar
- Li Y, Zhao M, Yin H, Gao F, Wu X, Luo Y, Zhao S, Zhang X, Su Y, Hu N, et al.: Overexpression of the growth arrest and DNA damage-induced 45α gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum. 2010, 62: 1438-1447. 10.1002/art.27363View ArticlePubMedGoogle Scholar
- Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM: IL-18-stimulated GADD45[beta] required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol. 2001, 2: 157-164.View ArticlePubMedGoogle Scholar
- Lu B, Yu H, Chow C-w, Li B, Zheng W-p, Davis RJ, Flavell RA: GADD45³ Mediates the Activation of the p38 and JNK MAP Kinase Pathways and Cytokine Production in Effector TH1 Cells. Immunity. 2001, 14: 583-590. 10.1016/S1074-7613(01)00141-8View ArticlePubMedGoogle Scholar
- Lu B, Ferrandino AF, Flavell RA: Gadd45[beta] is important for perpetuating cognate and inflammatory signals in T cells. Nat Immunol. 2004, 5: 38-44. 10.1038/ni1020View ArticlePubMedGoogle Scholar
- Yang Z, Song L, Huang C: Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades. Curr Cancer Drug Targets. 2009, 9: 915-930. 10.2174/156800909790192383View ArticlePubMedPubMed CentralGoogle Scholar
- Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Rosa-Leyva M, Vilardell-Tarrés M: Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology. 2008, 124: 339-347. 10.1111/j.1365-2567.2007.02771.xView ArticlePubMedPubMed CentralGoogle Scholar
- Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Vilardell-Tarres M: Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J Leukoc Biol. 2007, 81: 1609-1616. 10.1189/jlb.0107064View ArticlePubMedGoogle Scholar
- Quddus J, Johnson KJ, Gavalchin J, Amento EP, Chrisp CE, Yung RL, Richardson BC: Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest. 1993, 92: 38-53. 10.1172/JCI116576View ArticlePubMedPubMed CentralGoogle Scholar
- Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B: Demethylation of Promoter Regulatory Elements Contributes to Perforin Overexpression in CD4+ Lupus T Cells. J Immunol. 2004, 172: 3652-3661.View ArticlePubMedGoogle Scholar
- Bending D: Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest. 2009, 119: 565-572. 10.1172/JCI37865View ArticlePubMedPubMed CentralGoogle Scholar
- Streeck H, Cohen KW, Jolin JS, Brockman MA, Meier A, Power KA, Waring MT, Alter G, Altfeld M: Rapid ex vivo isolation and long-term culture of human Th17 cells. J Immunol Methods. 2008, 333: 115-125. 10.1016/j.jim.2008.01.018View ArticlePubMedGoogle Scholar